Gilead Sciences will open the doors to the company’s new operations site in North Raleigh, N.C., as part of a business services center expansion. Gilead’s second-quarter 2021 product sales increased 21 percent year-over-year, primarily driven by the Covid-19 antiviral treatment Veklury (remdesivir).
BioSpace takes a look at the flurry of expansion activity in the life sciences industry as biopharma and diagnostic companies expand manufacturing sites.
Regeneron continues to expand the company’s presence in New York. During the next six years, Regeneron will invest $1.8 billion to expand the company’s Tarrytown facilities. The investment will support the addition of 1,000 new jobs.
